272 related articles for article (PubMed ID: 33761923)
1. The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey.
Han AL
BMC Oral Health; 2021 Mar; 21(1):155. PubMed ID: 33761923
[TBL] [Abstract][Full Text] [Related]
2. Survey of Korean dentists on the awareness on bisphosphonate-related osteonecrosis of the jaws.
Yoo JY; Park YD; Kwon YD; Kim DY; Ohe JY
J Investig Clin Dent; 2010 Nov; 1(2):90-5. PubMed ID: 25427263
[TBL] [Abstract][Full Text] [Related]
3. Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients.
Yamori M; Tamura M; Mikami M; Mori T; Noi M; Machida Y; Koshinuma S; Yamamoto G
Int Dent J; 2021 Aug; 71(4):336-342. PubMed ID: 33518370
[TBL] [Abstract][Full Text] [Related]
4. Awareness and Attitude among Physicians Regarding Bisphosphonaterelated Osteonecrosis of the Jaw (BRONJ): A Cross-sectional Study.
Priyadarshini V; Ramachandra SS; Ganganna A
Curr Drug Saf; 2023; 18(3):361-367. PubMed ID: 35570536
[TBL] [Abstract][Full Text] [Related]
5. Awareness About Medication-Related Osteonecrosis of the Jaw Among Dental Professionals: A Multicentre Study.
Patil V; Acharya S; Vineetha R; Nikhil K
Oral Health Prev Dent; 2020 Jul; 18(3):505-509. PubMed ID: 32016175
[TBL] [Abstract][Full Text] [Related]
6. Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.
Miranda-Silva W; Montezuma MA; Benites BM; Bruno JS; Fonseca FP; Fregnani ER
Support Care Cancer; 2020 Nov; 28(11):5397-5404. PubMed ID: 32144584
[TBL] [Abstract][Full Text] [Related]
7. Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw.
Kim JW; Jeong SR; Kim SJ; Kim Y
BMC Oral Health; 2016 Sep; 16(1):92. PubMed ID: 27604159
[TBL] [Abstract][Full Text] [Related]
8. Cooperation between physicians and dentists for osteonecrosis of the jaw: a 2022 Japanese survey.
Taguchi A; Hagino H; Inoue D; Endo N; Society JO
J Bone Miner Metab; 2023 Nov; 41(6):829-837. PubMed ID: 37516668
[TBL] [Abstract][Full Text] [Related]
9. The trend of dental check-up and prevalence of dental complications following the use of bone modifying agents in patients with metastatic breast and prostate cancer: analysis of data from the Korean National Health Insurance Service.
Lim AR; Park W; Moon SJ; Kim MS; Lee S
BMC Health Serv Res; 2024 Apr; 24(1):412. PubMed ID: 38566103
[TBL] [Abstract][Full Text] [Related]
10. Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.
Alhussain A; Peel S; Dempster L; Clokie C; Azarpazhooh A
J Oral Maxillofac Surg; 2015 Jun; 73(6):1095-105. PubMed ID: 25843818
[TBL] [Abstract][Full Text] [Related]
11. Medical and Dental Professions' Varying Levels of Awareness Regarding Medication-related Osteonecrosis of the Jaw in Saudi Arabia? A Cross-sectional Study.
Aljohani MH; Aljohani AS; Aljohani RM; Alsharif WK; Nourwali I; Elsayed SA
J Contemp Dent Pract; 2024 Jan; 25(1):62-67. PubMed ID: 38514433
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: A survey of knowledge, attitudes, and practices among dentists in the principality of Asturias (Spain).
Escobedo M; García-Consuegra L; Junquera S; Olay S; Ascani G; Junquera L
J Stomatol Oral Maxillofac Surg; 2018 Nov; 119(5):395-400. PubMed ID: 29684638
[TBL] [Abstract][Full Text] [Related]
13. Qualitative focus group interview study of communication between patients, dentists and physicians for efficient osteonecrosis of the jaw practices.
Choi Y; Park H; Hong N; Rhee Y; Park W
BMJ Open; 2022 Mar; 12(3):e051054. PubMed ID: 35318228
[TBL] [Abstract][Full Text] [Related]
14. Physicians' awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis.
Supanumpar N; Pisarnturakit PP; Charatcharoenwitthaya N; Subbalekha K
PLoS One; 2024; 19(1):e0297500. PubMed ID: 38277387
[TBL] [Abstract][Full Text] [Related]
15. Awareness and practice of dentists in gulf cooperation council countries regarding medication-related osteonecrosis of the jaw - A web-based survey.
Nassani MZ; Tarakji B; Alqahtani AM; Alali FM; Noushad M; Rastam S; Alsalhani AB; Alfadel MK; Alzuabi AA; Ateen AM; Khojah AB; Zaman MU; Alqahtani AS; Alqhtani NR; Nabhan AB; Alhedyan FS; Kujan O; Al-Maweri SA
J Dent Sci; 2023 Oct; 18(4):1677-1684. PubMed ID: 37799864
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and attitude regarding bisphosphonates and related osteonecrosis among Turkish dentist: A cross sectional study.
Ozkan E; Bereket MC; Ozkan N
Niger J Clin Pract; 2021 Oct; 24(10):1485-1491. PubMed ID: 34657014
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays.
Damm DD; Jones DM
Gen Dent; 2013 Aug; 61(5):33-8. PubMed ID: 23928436
[TBL] [Abstract][Full Text] [Related]
18. Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw.
Taguchi A; Shiraki M; Sugimoto T; Ohta H; Soen S;
Curr Med Res Opin; 2016 Jul; 32(7):1261-8. PubMed ID: 27007294
[TBL] [Abstract][Full Text] [Related]
19. Oncologists awareness about bisphosphonate related osteonecrosis of the jaws.
Senturk MF; Cimen E; Tuzuner Oncul AM; Cambazoglu M
J Pak Med Assoc; 2016 Jul; 66(7):880-3. PubMed ID: 27427140
[TBL] [Abstract][Full Text] [Related]
20. A Dentist's Perspective on the Need for Interdisciplinary Collaboration to Reduce Medication-Related Osteonecrosis of the Jaw.
Griffin A; Brain P; Hancock C; Jeyapalina S
Sr Care Pharm; 2022 Sep; 37(9):458-467. PubMed ID: 36038998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
